<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="doi: 10.1016/j.celrep.2020.107915107915 : Article Potential Causes and Consequences of Gastrointestinal" exact="Disorders" post="during a SARS-CoV-2 Infection TrotteinFranÃ§oisfrancois.trottein@pasteur-lille.fr1âˆ—SokolHarry234[1], [2], [3], [4], âˆ—Corresponding"/>
 <result pre="Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2" exact="Infection" post="TrotteinFranÃ§oisfrancois.trottein@pasteur-lille.fr1âˆ—SokolHarry234[1], [2], [3], [4], âˆ—Corresponding author francois.trottein@pasteur-lille.fr pmc-release: 2020-7-7ppub:"/>
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="remains active. Abstract Coronaviruses cause several human diseases, including severe" exact="acute" post="respiratory syndrome. The global coronavirus disease 2019 (COVID-19) pandemic"/>
 <result pre="active. Abstract Coronaviruses cause several human diseases, including severe acute" exact="respiratory" post="syndrome. The global coronavirus disease 2019 (COVID-19) pandemic has"/>
 <result pre="human diseases, including severe acute respiratory syndrome. The global coronavirus" exact="disease" post="2019 (COVID-19) pandemic has become a huge threat to"/>
 <result pre="humans. Intensive research on the pathogenic mechanisms used by severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) is urgently neededâ€&quot;notably to"/>
 <result pre="Intensive research on the pathogenic mechanisms used by severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) is urgently neededâ€&quot;notably to identify"/>
 <result pre="research on the pathogenic mechanisms used by severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) is urgently neededâ€&quot;notably to identify potential"/>
 <result pre="shown that gastrointestinal disorders appear to precede or follow the" exact="respiratory" post="symptoms. Here, we review gastrointestinal disorders in patients with"/>
 <result pre="Lastly, we discuss the role of the gut microbiota during" exact="respiratory" post="viral infections and suggest that targeting gut dysbiosis may"/>
 <result pre="we discuss the role of the gut microbiota during respiratory" exact="viral" post="infections and suggest that targeting gut dysbiosis may help"/>
 <result pre="discuss the role of the gut microbiota during respiratory viral" exact="infections" post="and suggest that targeting gut dysbiosis may help to"/>
 <result pre="in patients with COVID-19 and discuss their potential consequences on" exact="disease" post="severity. They also discuss the role of the gut"/>
 <result pre="They also discuss the role of the gut microbiota in" exact="disease" post="and the potential interest of targeting it to improve"/>
 <result pre="pathogenesis. Keywords SARS-CoV-2 COVID-19 gastrointestinal symptoms gut microbiota microbial dysbiosis" exact="disease" post="outcomes Main Text Coronaviruses are enveloped RNA viruses containing"/>
 <result pre="viruses circulate continuously in human populations and generally cause mild" exact="respiratory" post="diseases, including the common cold. In contrast, the zoonotic"/>
 <result pre="diseases, including the common cold. In contrast, the zoonotic severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory"/>
 <result pre="including the common cold. In contrast, the zoonotic severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome"/>
 <result pre="the common cold. In contrast, the zoonotic severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus"/>
 <result pre="severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV) cause severe respiratory diseases and are"/>
 <result pre="acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV) cause severe respiratory diseases and are associated"/>
 <result pre="and the Middle East respiratory syndrome coronavirus (MERS-CoV) cause severe" exact="respiratory" post="diseases and are associated with a high mortality rate"/>
 <result pre="specific antiviral drugs or vaccines have been approved for combating" exact="infections" post="by SARS and MERS. In late 2019, a new"/>
 <result pre="infections by SARS and MERS. In late 2019, a new" exact="infectious" post="respiratory disease (now termed coronavirus disease 2019 [COVID-19]) emerged"/>
 <result pre="by SARS and MERS. In late 2019, a new infectious" exact="respiratory" post="disease (now termed coronavirus disease 2019 [COVID-19]) emerged in"/>
 <result pre="SARS and MERS. In late 2019, a new infectious respiratory" exact="disease" post="(now termed coronavirus disease 2019 [COVID-19]) emerged in Wuhan,"/>
 <result pre="late 2019, a new infectious respiratory disease (now termed coronavirus" exact="disease" post="2019 [COVID-19]) emerged in Wuhan, China (Wang etÂ al.,"/>
 <result pre="China (Wang etÂ al., 2020a; Zhu etÂ al., 2020). This" exact="disease" post="spread rapidly across China and to other countries. The"/>
 <result pre="related to SARS-CoV (nucleotide similarity: 89.1%). COVID-19 is characterized by" exact="acute" post="pathological outcomes, including pneumonia and acute respiratory distress syndrome"/>
 <result pre="similarity: 89.1%). COVID-19 is characterized by acute pathological outcomes, including" exact="pneumonia" post="and acute respiratory distress syndrome (ARDS), and has a"/>
 <result pre="COVID-19 is characterized by acute pathological outcomes, including pneumonia and" exact="acute" post="respiratory distress syndrome (ARDS), and has a substantial mortality"/>
 <result pre="is characterized by acute pathological outcomes, including pneumonia and acute" exact="respiratory" post="distress syndrome (ARDS), and has a substantial mortality rate"/>
 <result pre="by acute pathological outcomes, including pneumonia and acute respiratory distress" exact="syndrome" post="(ARDS), and has a substantial mortality rate (Chen etÂ"/>
 <result pre="mortality rate (Chen etÂ al., 2020). ARDS during a SARS-CoV-2" exact="infection" post="is also associated with dysregulation of cytokine production, barrier"/>
 <result pre="COVID-19 is more severe in individuals with comorbidities (diabetes mellitus," exact="cardiovascular" post="diseases, and hypertension) and in the elderly (Guan etÂ"/>
 <result pre="2020; Wu and McGoogan, 2020). SARS-CoV-2 Can Target the Gastrointestinal" exact="Tract" post="in Humans Both SARS-CoV and SARS-CoV-2 can infect host"/>
 <result pre="Both SARS-CoV and SARS-CoV-2 can infect host cells when the" exact="viral" post="spike protein binds to its cell surface receptor angiotensin-converting"/>
 <result pre="also requires cleavage of the spike protein (priming) by a" exact="type II" post="transmembrane serine protease called TMPRSS2. This priming step is"/>
 <result pre="TMPRSS2. This priming step is essential for fusion of the" exact="viral" post="and cell membranes (Matsuyama etÂ al., 2010; Hoffmann etÂ"/>
 <result pre="later, changes in ACE2â€™s functional activity might critically affect the" exact="disease" post="outcome. In humans, ACE2 and TMPRSS2 are strongly expressed"/>
 <result pre="are strongly expressed in lung tissue in general and by" exact="epithelial" post="cells in particular. This strong expression explains why the"/>
 <result pre="recent single-cell analysis revealed that more than 80% of ACE2-expressing" exact="pulmonary" post="cells were type II alveolar cells (Zhao etÂ al.,"/>
 <result pre="revealed that more than 80% of ACE2-expressing pulmonary cells were" exact="type II" post="alveolar cells (Zhao etÂ al., 2020); hence, this cell"/>
 <result pre="have a crucial role in coronavirus invasion and replication. Bronchial" exact="transient" post="secretory cells (with a phenotype between those of goblet"/>
 <result pre="express high levels of ACE2 (Lukassen etÂ al., 2020). Furthermore," exact="epithelial" post="cells in the upper respiratory tract (specifically nasal goblet/secretory"/>
 <result pre="ACE2 (Lukassen etÂ al., 2020). Furthermore, epithelial cells in the" exact="upper" post="respiratory tract (specifically nasal goblet/secretory cells and ciliated cells)"/>
 <result pre="(Lukassen etÂ al., 2020). Furthermore, epithelial cells in the upper" exact="respiratory" post="tract (specifically nasal goblet/secretory cells and ciliated cells) express"/>
 <result pre="TMPRSS2 (Sungnak etÂ al., 2020). This combined expression in the" exact="upper" post="airways may be correlated with enhanced transmission of the"/>
 <result pre="of ACE2 are found on the luminal surface of differentiated" exact="epithelial" post="cells in the small intestine, whereas levels are lower"/>
 <result pre="differentiated epithelial cells in the small intestine, whereas levels are" exact="lower" post="in the crypt cells and in the colon (Hashimoto"/>
 <result pre="a major entry site for SARS-CoV-2; this would suggest that" exact="consumption" post="of contaminated food can propagate the virus in humans."/>
 <result pre="essential implications for fecal-oral transmission and thus the containment of" exact="viral" post="spreading. As seen during previous coronavirus outbreaks, around half"/>
 <result pre="their stoolsâ€&quot;even when it is no longer found in the" exact="respiratory" post="tract (Zhang etÂ al., 2020; Xiao etÂ al., 2020b;"/>
 <result pre="endoscopy (Xiao etÂ al., 2020a; Lin etÂ al., 2020). Importantly," exact="infectious" post="viruses were detected in fecal samples of COVID-19 patients,"/>
 <result pre="suggesting that the digestive tract might be a site of" exact="viral" post="replication and activity (Xiao etÂ al., 2020b; Zhou etÂ"/>
 <result pre="(mouse system) reported that intragastric inoculation of SARS-CoV-2 causes productive" exact="infection" post="and leads to pulmonary pathological changes (Sun etÂ al.,"/>
 <result pre="intragastric inoculation of SARS-CoV-2 causes productive infection and leads to" exact="pulmonary" post="pathological changes (Sun etÂ al., 2020). Collectively, the lung"/>
 <result pre="is not the only site targeted by SARS-CoV-2, and enteric" exact="infection" post="occurs. Here, we review gastrointestinal disorders in patients with"/>
 <result pre="disorders on the outcome of the disease. SARS-CoV-2 Causes Gastrointestinal" exact="Disorders" post="in Humans Various research groups have analyzed the epidemiological"/>
 <result pre="at least one gastrointestinal tract symptom, the most common being" exact="diarrhea" post="(in 5% to 8% of patients). In the study"/>
 <result pre="a median of 4Â days and appeared to precede the" exact="respiratory" post="symptoms. Gastrointestinal symptoms were more frequent in severe/critical cases"/>
 <result pre="2020; Mao etÂ al., 2020; Sultan etÂ al., 2020). SARS-CoV-2" exact="infection" post="triggers an inflammatory response in the gut, as evidenced"/>
 <result pre="will be instrumental in better analyzing the modalities of enterocyte" exact="infection" post="and its impact on the inflammatory response. Furthermore, it"/>
 <result pre="to determine the consequences of pre-existing digestive diseases (i.e., inflammatory" exact="bowel" post="disease) on gastrointestinal disorders caused by SARS-CoV-2 and on"/>
 <result pre="and on the severity of COVID-19. Potential Mechanisms of Gastrointestinal" exact="Disorders" post="in COVID-19 Gastrointestinal disorders in COVID-19 patients are likely"/>
 <result pre="of inflammatory cells (i.e., from the bone marrow) and/or the" exact="systemic" post="and local production of inflammatory cytokines are likely to"/>
 <result pre="a role. In this setting, local inflammation might weaken the" exact="epithelial" post="barrier. Cellular damage induced directly by viral replication and"/>
 <result pre="might weaken the epithelial barrier. Cellular damage induced directly by" exact="viral" post="replication and spreading might also actively contribute to injury"/>
 <result pre="homeostasis, and a lack of this enzyme accentuates the intestineâ€™s" exact="susceptibility to" post="inflammation (Hashimoto etÂ al., 2012). The intestinal phenotype is"/>
 <result pre="expression of the neutral amino acid transporter B0AT1 on intestinal" exact="epithelial" post="cells, which lowers the intake of tryptophan and thus"/>
 <result pre="etÂ al., 2012; Agus etÂ al., 2018). Binding of the" exact="viral" post="spike protein to ACE2 leads to reduced expression of"/>
 <result pre="expression and impaired function of this protein during a SARS-CoV" exact="infection" post="might substantially contribute to local disorders and pathogenesis. It"/>
 <result pre="as ACE inhibitors or angiotensin II receptor blockers (used in" exact="hypertension" post="and diabetes), can modulate gastrointestinal disorders, including gut dysbiosis,"/>
 <result pre="might be implicated in gastrointestinal symptoms in COVID-19 patients. Because" exact="hypoxia" post="is a major clinical symptom in COVID-19 patients (Cavezzi"/>
 <result pre="that oxygen deprivation might be important in gastrointestinal disorders and" exact="disease" post="severity. Recent evidence suggests that SARS-CoV-2 may affect the"/>
 <result pre="disease severity. Recent evidence suggests that SARS-CoV-2 may affect the" exact="central nervous system" post="(Paniz-Mondolfi etÂ al., 2020; Helms etÂ al., 2020). Regarding"/>
 <result pre="nervous system could be affected by SARS-CoV-2, either by direct" exact="viral infection" post="or through the elicited immune response (e.g., inflammatory cytokines),"/>
 <result pre="system could be affected by SARS-CoV-2, either by direct viral" exact="infection" post="or through the elicited immune response (e.g., inflammatory cytokines),"/>
 <result pre="or through the elicited immune response (e.g., inflammatory cytokines), amplifying" exact="diarrhea" post="and possibly stimulating the vagus nerve to promote vomiting."/>
 <result pre="(e.g., inflammatory cytokines), amplifying diarrhea and possibly stimulating the vagus" exact="nerve" post="to promote vomiting. ACE2 Dysfunction Alters the Composition of"/>
 <result pre="and possibly stimulating the vagus nerve to promote vomiting. ACE2" exact="Dysfunction" post="Alters the Composition of the Gut Microbiota It is"/>
 <result pre="etÂ al., 2012). Moreover, disruption of the ACE/ACE2 axis during" exact="pulmonary" post="hypertension (loss of ACE2) is associated with alteration of"/>
 <result pre="al., 2012). Moreover, disruption of the ACE/ACE2 axis during pulmonary" exact="hypertension" post="(loss of ACE2) is associated with alteration of the"/>
 <result pre="can speculate that the decrease in ACE2 availability during SARS-COV-2" exact="infection" post="is enough to alter the composition of the gut"/>
 <result pre="microbiota. Recent pilot studies suggest gut microbiota alterations during SARS-CoV-2" exact="infection" post="(Yu etÂ al., 2020; Gu etÂ al., 2020b; Zuo"/>
 <result pre="COVID-19 patients (fecal sample analysis using 16S rRNA gene sequencing)," exact="infection" post="was associated with a significant decrease of bacterial diversity"/>
 <result pre="gene sequencing), infection was associated with a significant decrease of" exact="bacterial" post="diversity and abundance (Gu etÂ al., 2020b). Significant changes"/>
 <result pre="2020b). Significant changes in gut microbial communities were noticed, including" exact="lower" post="relative abundance of beneficial (butyrate-producing) bacteria, such as several"/>
 <result pre="a correlation between rise or drop of these bacteria and" exact="disease" post="severity. Of note, altered microbiota composition persisted after clearance"/>
 <result pre="microbiota composition persisted after clearance of SARS-CoV-2 and resolution of" exact="respiratory" post="symptoms, indicating that resiliency is long lasting (Zuo etÂ"/>
 <result pre="resiliency is long lasting (Zuo etÂ al., 2020). Hence, SARS-CoV-2" exact="infection" post="modifies the composition of the gut microbiota in humans."/>
 <result pre="Studies should prospectively include asymptomatic COVID-19-confirmed subjects and patients at" exact="disease" post="onset, during disease course, and over the long term"/>
 <result pre="include asymptomatic COVID-19-confirmed subjects and patients at disease onset, during" exact="disease" post="course, and over the long term after discovery to"/>
 <result pre="discovery to delineate the role of microbiome changes in SARS-CoV-2" exact="infection" post="and post-infection recovery. It will be critical to consider"/>
 <result pre="the comorbidity status of those patients. The consequences of SARS-CoV-2" exact="infection" post="on the gut microbiota should also be investigated in"/>
 <result pre="a mouse model, the altered gut microbiota associated with ACE2" exact="deficiency" post="(1) favors intestinal inflammation and (2) confers susceptibility to"/>
 <result pre="with ACE2 deficiency (1) favors intestinal inflammation and (2) confers" exact="susceptibility to" post="colitis when transferred to wild-type animals (Hashimoto etÂ al.,"/>
 <result pre="deficiency (1) favors intestinal inflammation and (2) confers susceptibility to" exact="colitis" post="when transferred to wild-type animals (Hashimoto etÂ al., 2012)."/>
 <result pre="COVID-19. FigureÂ 1 The Gut Microbiotaâ€™s Hypothetical Role in SARS-CoV-2" exact="Infection" post="A healthy gut microbiota boosts the lungsâ€™ antiviral response,"/>
 <result pre="leads to gut dysbiosis and gastrointestinal symptoms (step 3). Meanwhile," exact="viral infection" post="of the lungs triggers the systemic production of interferons"/>
 <result pre="to gut dysbiosis and gastrointestinal symptoms (step 3). Meanwhile, viral" exact="infection" post="of the lungs triggers the systemic production of interferons"/>
 <result pre="(step 3). Meanwhile, viral infection of the lungs triggers the" exact="systemic" post="production of interferons and elicits weight loss, both of"/>
 <result pre="microbiota and impairment of the gutâ€™s barrier function contribute to" exact="disease" post="outcomes, including ARDS, a systemic cytokine storm, and multiorgan"/>
 <result pre="gutâ€™s barrier function contribute to disease outcomes, including ARDS, a" exact="systemic" post="cytokine storm, and multiorgan dysfunction (step 4). The Potential"/>
 <result pre="the gut microbiota can remotely boost the hostâ€™s response to" exact="respiratory" post="viral infections. Paradoxically, dysbiosis of the microbiota can also"/>
 <result pre="gut microbiota can remotely boost the hostâ€™s response to respiratory" exact="viral" post="infections. Paradoxically, dysbiosis of the microbiota can also worsen"/>
 <result pre="outcome of the disease. The gut microbiotaâ€™s role in hCoV" exact="infections" post="has yet to be defined. In the setting of"/>
 <result pre="the results of experiments with antibiotic treatment (to deplete the" exact="residual" post="microbiota) have demonstrated that the gut microbiota is critical"/>
 <result pre="have demonstrated that the gut microbiota is critical for controlling" exact="viral" post="replication (Ichinohe etÂ al., 2011; Abt etÂ al., 2012;"/>
 <result pre="2017; Bradley etÂ al., 2019). Bacterial cell wall components and" exact="bacterial" post="metabolites (such as desaminotyrosine) favor the production of type"/>
 <result pre="and bacterial metabolites (such as desaminotyrosine) favor the production of" exact="type I" post="interferons and inflammasome-dependent cytokines by pulmonary cells. The gut"/>
 <result pre="the production of type I interferons and inflammasome-dependent cytokines by" exact="pulmonary" post="cells. The gut microbiota also boosts CD8+ TÂ cell"/>
 <result pre="CD8+ TÂ cell effector function, a process that contributes to" exact="viral" post="clearance (Ichinohe etÂ al., 2011). Whereas altering the gut"/>
 <result pre="al., 2018). Similar protective effects have been observed with the" exact="respiratory" post="syncytial virus (Antunes etÂ al., 2019). It remains to"/>
 <result pre="and/or probiotics on the outcome of SARS-CoV-2 infection. Patients with" exact="respiratory" post="infections generally have gut-dysfunction-related complications that worsen the clinical"/>
 <result pre="probiotics on the outcome of SARS-CoV-2 infection. Patients with respiratory" exact="infections" post="generally have gut-dysfunction-related complications that worsen the clinical course."/>
 <result pre="this type of gut-lung crosstalk has been described during influenza" exact="infections" post="in both humans and animal models. Severe influenza A"/>
 <result pre="described during influenza infections in both humans and animal models." exact="Severe" post="influenza A virus infection is associated with intestinal disorders"/>
 <result pre="infections in both humans and animal models. Severe influenza A" exact="virus infection" post="is associated with intestinal disorders and gut microbiota alterations"/>
 <result pre="in both humans and animal models. Severe influenza A virus" exact="infection" post="is associated with intestinal disorders and gut microbiota alterations"/>
 <result pre="These changes were attributed partly to infection-related reduction in food" exact="consumption" post="(Sencio etÂ al., 2020) and to interferon production (Wang"/>
 <result pre="looked at whether microbiota conditioned by influenza A virus enhanced" exact="susceptibility to" post="bacterial superinfection, a major cause of mortality during epidemics"/>
 <result pre="whether microbiota conditioned by influenza A virus enhanced susceptibility to" exact="bacterial" post="superinfection, a major cause of mortality during epidemics and"/>
 <result pre="COVID-19 is still an open question. Evidence suggests that SARS-CoV-2" exact="infection" post="alters the gut-blood barrier and thus leads to systemic"/>
 <result pre="SARS-CoV-2 infection alters the gut-blood barrier and thus leads to" exact="systemic" post="dissemination of bacteria, endotoxins, and microbial metabolites (Wang etÂ"/>
 <result pre="2020). This might affect the hostâ€™s initial response to SARS-CoV-2" exact="infection" post="and might then contribute to multisystem dysfunction, septic shock,"/>
 <result pre="to SARS-CoV-2 infection and might then contribute to multisystem dysfunction," exact="septic shock," post="and the systemic inflammation storm seen in the second"/>
 <result pre="might then contribute to multisystem dysfunction, septic shock, and the" exact="systemic" post="inflammation storm seen in the second phase of SARS-CoV-2"/>
 <result pre="2020c). Clinical studies have demonstrated that the presence of a" exact="gastrointestinal disorder" post="in COVID-19 patients is associated with a more aggressive"/>
 <result pre="of SCFAs. This is particularly the case for patients with" exact="metabolic syndrome" post="(obesity, high blood pressure, and diabetes) who exhibit severity"/>
 <result pre="SCFAs. This is particularly the case for patients with metabolic" exact="syndrome" post="(obesity, high blood pressure, and diabetes) who exhibit severity"/>
 <result pre="is particularly the case for patients with metabolic syndrome (obesity," exact="high blood pressure," post="and diabetes) who exhibit severity factors for viral infections"/>
 <result pre="high blood pressure, and diabetes) who exhibit severity factors for" exact="viral" post="infections (including respiratory infections) (Badawi etÂ al., 2018; Honce"/>
 <result pre="blood pressure, and diabetes) who exhibit severity factors for viral" exact="infections" post="(including respiratory infections) (Badawi etÂ al., 2018; Honce and"/>
 <result pre="and diabetes) who exhibit severity factors for viral infections (including" exact="respiratory" post="infections) (Badawi etÂ al., 2018; Honce and Schultz-Cherry, 2019)."/>
 <result pre="in microbial profiles, and intestinal inflammation and leakiness during SARS-CoV" exact="infection" post="strongly amplify systemic pathways in comorbid individuals and exacerbate"/>
 <result pre="and intestinal inflammation and leakiness during SARS-CoV infection strongly amplify" exact="systemic" post="pathways in comorbid individuals and exacerbate underlying pathologies (e.g.,"/>
 <result pre="systemic pathways in comorbid individuals and exacerbate underlying pathologies (e.g.," exact="diabetes" post="and hypertension). SARS-CoV-2 infection may also deteriorate the course"/>
 <result pre="individuals and exacerbate underlying pathologies (e.g., diabetes and hypertension). SARS-CoV-2" exact="infection" post="may also deteriorate the course of human inflammatory bowel"/>
 <result pre="hypertension). SARS-CoV-2 infection may also deteriorate the course of human" exact="inflammatory bowel diseases" post="(Effenberger etÂ al., 2020). The mortality rate associated with"/>
 <result pre="SARS-CoV-2 infection may also deteriorate the course of human inflammatory" exact="bowel" post="diseases (Effenberger etÂ al., 2020). The mortality rate associated"/>
 <result pre="(Effenberger etÂ al., 2020). The mortality rate associated with SARS-CoV-2" exact="infection" post="is higher in older adults, who also tend to"/>
 <result pre="is higher in older adults, who also tend to display" exact="chronic" post="low-grade inflammation with underlying microbiota alterations and gut leakiness."/>
 <result pre="a therapeutic option. Concluding Remarks The complex pathogenesis of SARS-CoV-2" exact="infection" post="is only starting to be deciphered. Along with the"/>
 <result pre="infection is only starting to be deciphered. Along with the" exact="respiratory" post="tract, the gastrointestinal tract is an entry and replication"/>
 <result pre="explored. In particular, several lines of evidence suggest that SARS-CoV-2" exact="infection" post="is associated with alteration of the gut microbiota. It"/>
 <result pre="be determined whether the gut microbiota influences the gastrointestinal and" exact="pulmonary" post="signs and symptoms of COVID-19 and overall mortality. Putative"/>
 <result pre="gut microbiotaâ€™s composition and functional activity might be biomarkers of" exact="disease" post="severity. Lastly, and if the gut microbiota does prove"/>
 <result pre="diseaseCell Host Microbe23201871672429902437 AntunesK.H.FachiJ.L.de PaulaR.da SilvaE.F.PralL.P.Dos SantosA.Ã�.DiasG.B.M.VargasJ.E.PugaR.MayerF.Q.Microbiota-derived acetate protects against" exact="respiratory" post="syncytial virus infection through a GPR43-type 1 interferon responseNat."/>
 <result pre="Microbe23201871672429902437 AntunesK.H.FachiJ.L.de PaulaR.da SilvaE.F.PralL.P.Dos SantosA.Ã�.DiasG.B.M.VargasJ.E.PugaR.MayerF.Q.Microbiota-derived acetate protects against respiratory syncytial" exact="virus infection" post="through a GPR43-type 1 interferon responseNat. Commun.1020193273328931332169 BadawiA.VelummailumR.RyooS.G.SenthinathanA.YaghoubiS.VasilevaD.OstermeierE.PlishkaM.SoosaipillaiM.AroraP.Prevalence of"/>
 <result pre="AntunesK.H.FachiJ.L.de PaulaR.da SilvaE.F.PralL.P.Dos SantosA.Ã�.DiasG.B.M.VargasJ.E.PugaR.MayerF.Q.Microbiota-derived acetate protects against respiratory syncytial virus" exact="infection" post="through a GPR43-type 1 interferon responseNat. Commun.1020193273328931332169 BadawiA.VelummailumR.RyooS.G.SenthinathanA.YaghoubiS.VasilevaD.OstermeierE.PlishkaM.SoosaipillaiM.AroraP.Prevalence of"/>
 <result pre="infection through a GPR43-type 1 interferon responseNat. Commun.1020193273328931332169 BadawiA.VelummailumR.RyooS.G.SenthinathanA.YaghoubiS.VasilevaD.OstermeierE.PlishkaM.SoosaipillaiM.AroraP.Prevalence of" exact="chronic" post="comorbidities in dengue fever and West Nile virus: A"/>
 <result pre="GPR43-type 1 interferon responseNat. Commun.1020193273328931332169 BadawiA.VelummailumR.RyooS.G.SenthinathanA.YaghoubiS.VasilevaD.OstermeierE.PlishkaM.SoosaipillaiM.AroraP.Prevalence of chronic comorbidities in" exact="dengue fever" post="and West Nile virus: A systematic review and meta-analysisPLoS"/>
 <result pre="CallawayE.Labs rush to study coronavirus in transgenic animalsâ€&quot;some are in" exact="short" post="supplyNature5792020183 CavezziA.TroianiE.CorraoS.COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A"/>
 <result pre="transgenic animalsâ€&quot;some are in short supplyNature5792020183 CavezziA.TroianiE.CorraoS.COVID-19: hemoglobin, iron, and" exact="hypoxia" post="beyond inflammation. A narrative reviewClin. Pract.1020201271127732509258 ChenG.WuD.GuoW.CaoY.HuangD.WangH.WangT.ZhangX.ChenH.YuH.Clinical and immunological"/>
 <result pre="Pract.1020201271127732509258 ChenG.WuD.GuoW.CaoY.HuangD.WangH.WangT.ZhangX.ChenH.YuH.Clinical and immunological features of severe and moderate coronavirus" exact="disease" post="2019J.Â Clin. Invest.13020202620262932217835 CheungK.S.HungI.F.N.ChanP.P.Y.LungK.C.TsoE.LiuR.NgY.Y.ChuM.Y.ChungT.W.H.TamA.R.Gastrointestinal manifestations of SARS-CoV-2 infection and"/>
 <result pre="moderate coronavirus disease 2019J.Â Clin. Invest.13020202620262932217835 CheungK.S.HungI.F.N.ChanP.P.Y.LungK.C.TsoE.LiuR.NgY.Y.ChuM.Y.ChungT.W.H.TamA.R.Gastrointestinal manifestations of SARS-CoV-2" exact="infection" post="and virus load in fecal samples from a Hong"/>
 <result pre="Res.176202010474210474632057769 CrackowerM.A.SaraoR.OuditG.Y.YagilC.KozieradzkiI.ScangaS.E.Oliveira-dos-SantosA.J.da CostaJ.ZhangL.PeiY.Angiotensin-converting enzyme 2 is an essential regulator of" exact="heart" post="functionNature417200282282812075344 DeriuE.BoxxG.M.HeX.PanC.BenavidezS.D.CenL.RozengurtN.ShiW.ChengG.Influenza virus affects intestinal microbiota and secondary Salmonella"/>
 <result pre="regulator of heart functionNature417200282282812075344 DeriuE.BoxxG.M.HeX.PanC.BenavidezS.D.CenL.RozengurtN.ShiW.ChengG.Influenza virus affects intestinal microbiota and" exact="secondary" post="Salmonella infection in the gut through type I interferonsPLoS"/>
 <result pre="of heart functionNature417200282282812075344 DeriuE.BoxxG.M.HeX.PanC.BenavidezS.D.CenL.RozengurtN.ShiW.ChengG.Influenza virus affects intestinal microbiota and secondary" exact="Salmonella infection" post="in the gut through type I interferonsPLoS Pathog.122016e100557227149619 EffenbergerM.GrabherrF.MayrL.SchwaerzlerJ.NairzM.SeifertM.HilbeR.SeiwaldS.Scholl-BuergiS.FritscheG.Faecal"/>
 <result pre="heart functionNature417200282282812075344 DeriuE.BoxxG.M.HeX.PanC.BenavidezS.D.CenL.RozengurtN.ShiW.ChengG.Influenza virus affects intestinal microbiota and secondary Salmonella" exact="infection" post="in the gut through type I interferonsPLoS Pathog.122016e100557227149619 EffenbergerM.GrabherrF.MayrL.SchwaerzlerJ.NairzM.SeifertM.HilbeR.SeiwaldS.Scholl-BuergiS.FritscheG.Faecal"/>
 <result pre="intestinal microbiota and secondary Salmonella infection in the gut through" exact="type I" post="interferonsPLoS Pathog.122016e100557227149619 EffenbergerM.GrabherrF.MayrL.SchwaerzlerJ.NairzM.SeifertM.HilbeR.SeiwaldS.Scholl-BuergiS.FritscheG.Faecal calprotectin indicates intestinal inflammation in COVID-19Gut202010.1136/gutjnl-2020-321388Published"/>
 <result pre="intestinal inflammation in COVID-19Gut202010.1136/gutjnl-2020-321388Published online April 20, 2020 FehrA.R.ChannappanavarR.PerlmanS.Middle East" exact="Respiratory" post="Syndrome: Emergence of a Pathogenic Human CoronavirusAnnu. Rev. Med.68201738739927576010"/>
 <result pre="the 20th anniversary of the discovery of ACE2Circ. Res.12620201456147432264791 GrovesH.T.CuthbertsonL.JamesP.MoffattM.F.CoxM.J.TregoningJ.S.Respiratory" exact="Disease" post="following Viral Lung Infection Alters the Murine Gut MicrobiotaFront."/>
 <result pre="anniversary of the discovery of ACE2Circ. Res.12620201456147432264791 GrovesH.T.CuthbertsonL.JamesP.MoffattM.F.CoxM.J.TregoningJ.S.Respiratory Disease following" exact="Viral" post="Lung Infection Alters the Murine Gut MicrobiotaFront. Immunol.9201818219329483910 GuS.ChenY.WuZ.ChenY.GaoH.LvL.GuoF.ZhangX.LuoR.HuangC.Alterations"/>
 <result pre="the discovery of ACE2Circ. Res.12620201456147432264791 GrovesH.T.CuthbertsonL.JamesP.MoffattM.F.CoxM.J.TregoningJ.S.Respiratory Disease following Viral Lung" exact="Infection" post="Alters the Murine Gut MicrobiotaFront. Immunol.9201818219329483910 GuS.ChenY.WuZ.ChenY.GaoH.LvL.GuoF.ZhangX.LuoR.HuangC.Alterations of the"/>
 <result pre="China Medical Treatment Expert Group for Covid-19Clinical characteristics of Coronavirus" exact="Disease" post="2019 in ChinaN.Â Engl. J. Med.38220201708172032109013 HammingI.TimensW.BulthuisM.L.C.LelyA.T.NavisG.van GoorH.Tissue distribution"/>
 <result pre="step in understanding SARS pathogenesisJ.Â Pathol.203200463163715141377 HashimotoT.PerlotT.RehmanA.TrichereauJ.IshiguroH.PaolinoM.SiglV.HanadaT.HanadaR.LipinskiS.ACE2 links amino acid" exact="malnutrition" post="to microbial ecology and intestinal inflammationNature487201247748122837003 HelmsJ.KremerS.MerdjiH.Clere-JehlR.SchenckM.KummerlenC.CollangeO.BoulayC.Fafi-KremerS.OhanaM.Neurologic features in"/>
 <result pre="malnutrition to microbial ecology and intestinal inflammationNature487201247748122837003 HelmsJ.KremerS.MerdjiH.Clere-JehlR.SchenckM.KummerlenC.CollangeO.BoulayC.Fafi-KremerS.OhanaM.Neurologic features in" exact="Severe" post="SARS-CoV-2 infectionN.Â Engl. J. Med.38220202268227032294339 HoffmannM.Kleine-WeberH.SchroederS.KrÃ¼gerN.HerrlerT.ErichsenS.SchiergensT.S.HerrlerG.WuN.H.NitscheA.SARS-CoV-2 cell entry depends"/>
 <result pre="is blocked by a clinically proven protease inhibitorCell1812020271280.e832142651 HonceR.Schultz-CherryS.Impact of" exact="obesity" post="on Influenza A Virus pathogenesis, immune response, and evolutionFront."/>
 <result pre="novel coronavirus in Wuhan, ChinaLancet395202049750631986264 IchinoheT.PangI.K.KumamotoY.PeaperD.R.HoJ.H.MurrayT.S.IwasakiA.Microbiota regulates immune defense against" exact="respiratory" post="tract influenza A virus infectionProc. Natl. Acad. Sci. USA10820115354535921402903"/>
 <result pre="JinX.LianJ.S.HuJ.H.GaoJ.ZhengL.ZhangY.M.HaoS.R.JiaH.Y.CaiH.ZhangX.L.Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected" exact="disease" post="2019 (COVID-19) with gastrointestinal symptomsGut6920201002100932213556 KimS.RigattoK.GazzanaM.B.KnorstM.M.RichardsE.M.PepineC.J.RaizadaM.K.Altered gut microbiome profile"/>
 <result pre="with gastrointestinal symptomsGut6920201002100932213556 KimS.RigattoK.GazzanaM.B.KnorstM.M.RichardsE.M.PepineC.J.RaizadaM.K.Altered gut microbiome profile in patients with" exact="pulmonary" post="arterial hypertensionHypertension7520201063107132088998 KubaK.ImaiY.RaoS.GaoH.GuoF.GuanB.HuanY.YangP.ZhangY.DengW.A crucial role of angiotensin converting enzyme"/>
 <result pre="1, 2020 LavelleA.SokolH.Gut microbiota-derived metabolites as key actors in inflammatory" exact="bowel" post="diseaseNat. Rev. Gastroenterol. Hepatol.17202022323732076145 LiangW.FengZ.RaoS.XiaoC.XueX.LinZ.ZhangQ.QiW.Diarrhoea may be underestimated: a"/>
 <result pre="LukassenS.ChuaR.L.TrefzerT.KahnN.C.SchneiderM.A.MuleyT.WinterH.MeisterM.VeithC.BootsA.W.SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial" exact="transient" post="secretory cellsEMBO J.392020e10511432246845 MaoR.QiuY.HeJ.S.TanJ.Y.LiX.H.LiangJ.ShenJ.ZhuL.R.ChenY.IacucciM.Manifestations and prognosis of gastrointestinal and"/>
 <result pre="review and meta-analysisLancet Gastroenterol. Hepatol.5202066767832405603 MatsuyamaS.NagataN.ShiratoK.KawaseM.TakedaM.TaguchiF.Efficient activation of the severe" exact="acute" post="respiratory syndrome coronavirus spike protein by the transmembrane protease"/>
 <result pre="and meta-analysisLancet Gastroenterol. Hepatol.5202066767832405603 MatsuyamaS.NagataN.ShiratoK.KawaseM.TakedaM.TaguchiF.Efficient activation of the severe acute" exact="respiratory" post="syndrome coronavirus spike protein by the transmembrane protease TMPRSS2J.Â"/>
 <result pre="meta-analysisLancet Gastroenterol. Hepatol.5202066767832405603 MatsuyamaS.NagataN.ShiratoK.KawaseM.TakedaM.TaguchiF.Efficient activation of the severe acute respiratory" exact="syndrome" post="coronavirus spike protein by the transmembrane protease TMPRSS2J.Â Virol.842010126581266420926566"/>
 <result pre="bacteria in the lungNat. Rev. Microbiol.12201425226224590244 NobelY.R.PhippsM.ZuckerJ.LebwohlB.WangT.C.SobieszczykM.E.FreedbergD.E.Gastrointestinal symptoms and coronavirus" exact="disease" post="2019: a case-control study from the United StatesGastroenterology202010.1053/j.gastro.2020.04.017Published online"/>
 <result pre="multicenter studyAm. J. Gastroenterol.115202076677332287140 Paniz-MondolfiA.BryceC.GrimesZ.GordonR.E.ReidyJ.LednickyJ.SordilloE.M.FowkesM.Central nervous system involvement by severe" exact="acute" post="respiratory syndrome coronavirus-2 (SARS-CoV-2)J.Â Med. Virol.92202069970232314810 QinN.ZhengB.YaoJ.GuoL.ZuoJ.WuL.ZhouJ.LiuL.GuoJ.NiS.Influence of H7N9"/>
 <result pre="studyAm. J. Gastroenterol.115202076677332287140 Paniz-MondolfiA.BryceC.GrimesZ.GordonR.E.ReidyJ.LednickyJ.SordilloE.M.FowkesM.Central nervous system involvement by severe acute" exact="respiratory" post="syndrome coronavirus-2 (SARS-CoV-2)J.Â Med. Virol.92202069970232314810 QinN.ZhengB.YaoJ.GuoL.ZuoJ.WuL.ZhouJ.LiuL.GuoJ.NiS.Influence of H7N9 virus"/>
 <result pre="J. Gastroenterol.115202076677332287140 Paniz-MondolfiA.BryceC.GrimesZ.GordonR.E.ReidyJ.LednickyJ.SordilloE.M.FowkesM.Central nervous system involvement by severe acute respiratory" exact="syndrome" post="coronavirus-2 (SARS-CoV-2)J.Â Med. Virol.92202069970232314810 QinN.ZhengB.YaoJ.GuoL.ZuoJ.WuL.ZhouJ.LiuL.GuoJ.NiS.Influence of H7N9 virus infection"/>
 <result pre="acute respiratory syndrome coronavirus-2 (SARS-CoV-2)J.Â Med. Virol.92202069970232314810 QinN.ZhengB.YaoJ.GuoL.ZuoJ.WuL.ZhouJ.LiuL.GuoJ.NiS.Influence of H7N9" exact="virus infection" post="and associated treatment on human gut microbiotaSci. Rep.52015147711478426490635 RanjbarR.ShafieeM.HesariA.FernsG.A.GhasemiF.AvanA.The"/>
 <result pre="respiratory syndrome coronavirus-2 (SARS-CoV-2)J.Â Med. Virol.92202069970232314810 QinN.ZhengB.YaoJ.GuoL.ZuoJ.WuL.ZhouJ.LiuL.GuoJ.NiS.Influence of H7N9 virus" exact="infection" post="and associated treatment on human gut microbiotaSci. Rep.52015147711478426490635 RanjbarR.ShafieeM.HesariA.FernsG.A.GhasemiF.AvanA.The"/>
 <result pre="ReddW.D.ZhouJ.C.HathornK.E.McCartyT.R.BazarbashiA.N.ThompsonC.C.ShenL.ChanW.W.Prevalence and characteristics of gastrointestinal symptoms in patients with SARS-CoV-2" exact="infection" post="in the United States: A multicenter cohort studyGastroenterology202010.1053/j.gastro.2020.04.045Published online"/>
 <result pre="studyGastroenterology202010.1053/j.gastro.2020.04.045Published online April 22, 2020 SantistebanM.M.KimS.PepineC.J.RaizadaM.K.Brain-gut-bone marrow axis: Implications for" exact="hypertension" post="and related therapeuticsCirc. Res.11820161327133627081113 SencioV.BarthelemyA.TavaresL.P.MachadoM.G.SoulardD.CuinatC.Queiroz-JuniorC.M.NoordineM.L.SalomÃ©-DesnoulezS.DeryuterL.Gut dysbiosis during influenza contributes"/>
 <result pre="and related therapeuticsCirc. Res.11820161327133627081113 SencioV.BarthelemyA.TavaresL.P.MachadoM.G.SoulardD.CuinatC.Queiroz-JuniorC.M.NoordineM.L.SalomÃ©-DesnoulezS.DeryuterL.Gut dysbiosis during influenza contributes to" exact="pulmonary" post="pneumococcal superinfection through altered short-chain fatty acid productionCell Rep.30202029342947.e632130898"/>
 <result pre="and practical considerationsDiabetes Metab. Syndr.14202030331032298981 SinghalR.ShahY.M.Oxygen battle in the gut:" exact="hypoxia" post="and hypoxia-inducible factors in metabolic and inflammatory responses in"/>
 <result pre="5, 2020 SteedA.L.ChristophiG.P.KaikoG.E.SunL.GoodwinV.M.JainU.EsaulovaE.ArtyomovM.N.MoralesD.J.HoltzmanM.J.The microbial metabolite desaminotyrosine protects from influenza through" exact="type I" post="interferonScience357201749850228774928 SultanS.AltayarO.SiddiqueS.M.DavitkovP.FeuersteinJ.D.LimJ.K.Falck-YtterY.El-SeragH.B.collab: American Gastroenterological AssociationAGA institute rapid review of"/>
 <result pre="metabolite desaminotyrosine protects from influenza through type I interferonScience357201749850228774928 SultanS.AltayarO.SiddiqueS.M.DavitkovP.FeuersteinJ.D.LimJ.K.Falck-YtterY.El-SeragH.B.collab:" exact="American" post="Gastroenterological AssociationAGA institute rapid review of the gastrointestinal and"/>
 <result pre="COVID-19Gastroenterology202010.1053/j.gastro.2020.05.001Published online May 11, 2020 SunS.-H.ChenQ.GuH.-J.YangG.WangY.-X.HuangX.-Y.LiuS.-S.ZhangN.-N.LiX.-F.XiongR.A mouse model of SARS-CoV-2" exact="infection" post="and pathogenesisCell Host Microbe202010.1016/j.chom.2020.05.020Published online May 27, 2020 SungnakW.HuangN.BÃ©cavinC.BergM.QueenR.LitvinukovaM.Talavera-LÃ³pezC.MaatzH.ReichartD.SampaziotisF.collab:"/>
 <result pre="Lung Biological NetworkSARS-CoV-2 entry factors are highly expressed in nasal" exact="epithelial" post="cells together with innate immune genesNat. Med.26202068168732327758 TrompetteA.GollwitzerE.S.PattaroniC.Lopez-MejiaI.C.RivaE.PernotJ.UbagsN.FajasL.NicodL.P.MarslandB.J.Dietary fiber"/>
 <result pre="TrompetteA.GollwitzerE.S.PattaroniC.Lopez-MejiaI.C.RivaE.PernotJ.UbagsN.FajasL.NicodL.P.MarslandB.J.Dietary fiber confers protection against flu by shaping Ly6câˆ’ patrolling" exact="monocyte" post="hematopoiesis and CD8+ TÂ cell metabolismImmunity4820189921005.e829768180 WangJ.LiF.WeiH.LianZ.-X.SunR.TianZ.Respiratory influenza virus"/>
 <result pre="patrolling monocyte hematopoiesis and CD8+ TÂ cell metabolismImmunity4820189921005.e829768180 WangJ.LiF.WeiH.LianZ.-X.SunR.TianZ.Respiratory influenza" exact="virus infection" post="induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammationJ.Â"/>
 <result pre="monocyte hematopoiesis and CD8+ TÂ cell metabolismImmunity4820189921005.e829768180 WangJ.LiF.WeiH.LianZ.-X.SunR.TianZ.Respiratory influenza virus" exact="infection" post="induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammationJ.Â"/>
 <result pre="WangD.HuB.HuC.ZhuF.LiuX.ZhangJ.WangB.XiangH.ChengZ.XiongY.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected" exact="pneumonia" post="in Wuhan, ChinaJAMA323202010611069 WuZ.McGooganJ.M.Characteristics of and important lessons from"/>
 <result pre="Wuhan, ChinaJAMA323202010611069 WuZ.McGooganJ.M.Characteristics of and important lessons from the Coronavirus" exact="disease" post="2019 (COVID-19) outbreak in China: summary of a report"/>
 <result pre="report of 72Â 314 cases from the Chinese center for" exact="disease" post="control and preventionJAMA202010.1001/jama.2020.2648Published online February 24, 2020 XiaoF.TangM.ZhengX.LiuY.LiX.ShanH.Evidence for"/>
 <result pre="control and preventionJAMA202010.1001/jama.2020.2648Published online February 24, 2020 XiaoF.TangM.ZhengX.LiuY.LiX.ShanH.Evidence for gastrointestinal" exact="infection" post="of SARS-CoV-2Gastroenterology158202018311833.e332142773 XiaoF.SunJ.XuY.LiF.HuandX.LiH.ZhoaJ.HuangJ.ZhaoJ.Infectious SARS-CoV-2 in feces of patient with"/>
 <result pre="infection of SARS-CoV-2Gastroenterology158202018311833.e332142773 XiaoF.SunJ.XuY.LiF.HuandX.LiH.ZhoaJ.HuangJ.ZhaoJ.Infectious SARS-CoV-2 in feces of patient with" exact="Severe" post="COVID-19Emerg. Infect. Dis.26202010.3201/eid2608.200681Published online May 18, 2020 YildizS.Mazel-SanchezB.KandasamyM.ManicassamyB.SchmolkeM.Influenza A"/>
 <result pre="Severe COVID-19Emerg. Infect. Dis.26202010.3201/eid2608.200681Published online May 18, 2020 YildizS.Mazel-SanchezB.KandasamyM.ManicassamyB.SchmolkeM.Influenza A" exact="virus infection" post="impacts systemic microbiota dynamics and causes quantitative enteric dysbiosisMicrobiome6201892529321057"/>
 <result pre="COVID-19Emerg. Infect. Dis.26202010.3201/eid2608.200681Published online May 18, 2020 YildizS.Mazel-SanchezB.KandasamyM.ManicassamyB.SchmolkeM.Influenza A virus" exact="infection" post="impacts systemic microbiota dynamics and causes quantitative enteric dysbiosisMicrobiome6201892529321057"/>
 <result pre="Dis.26202010.3201/eid2608.200681Published online May 18, 2020 YildizS.Mazel-SanchezB.KandasamyM.ManicassamyB.SchmolkeM.Influenza A virus infection impacts" exact="systemic" post="microbiota dynamics and causes quantitative enteric dysbiosisMicrobiome6201892529321057 YuL.TongY.ShenG.FuA.LaiY.ZhouX.YanY.WangY.PanY.YuZ.Immunodepletion with"/>
 <result pre="YuL.TongY.ShenG.FuA.LaiY.ZhouX.YanY.WangY.PanY.YuZ.Immunodepletion with hypoxemia: A potential high risk subtype of coronavirus" exact="disease" post="2019medRxiv202010.1101/2020.03.03.20030650 ZangR.Gomez CastroM.F.McCuneB.T.ZengQ.RothlaufP.W.SonnekN.M.LiuZ.BruloisK.F.WangX.GreenbergH.B.TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of"/>
 <result pre="of coronavirus disease 2019medRxiv202010.1101/2020.03.03.20030650 ZangR.Gomez CastroM.F.McCuneB.T.ZengQ.RothlaufP.W.SonnekN.M.LiuZ.BruloisK.F.WangX.GreenbergH.B.TMPRSS2 and TMPRSS4 promote SARS-CoV-2" exact="infection" post="of human small intestinal enterocytesSci. Immunol.52020eabc358232404436 ZhangW.DuR.H.LiB.ZhengX.S.YangX.L.HuB.WangY.Y.XiaoG.F.YanB.ShiZ.L.ZhouP.Molecular and serological"/>
 <result pre="profiling of ACE2, the putative receptor of Wuhan 2019-nCovbioRxiv202010.1101/2020.01.26.919985 ZhouP.YangX.L.WangX.G.HuB.ZhangL.ZhangW.SiH.R.ZhuY.LiB.HuangC.L.A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
 <result pre="Coronavirus Investigating and Research TeamA Novel Coronavirus from Patients with" exact="Pneumonia" post="in China, 2019N.Â Engl. J. Med.382202072773331978945 ZuoT.ZhangF.LuiG.C.Y.YeohY.K.LiA.Y.L.ZhanH.WanY.ChungA.CheungC.P.ChenN.Alterations in gut"/>
</results>
